![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 19, 16374-16378, May 11, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of Molecular Pharmacology and
Phosphoinositide (PI) 3-kinases are
required for the acute regulation of the cytoskeleton by growth
factors. We have shown previously that in the MTLn3 rat adenocarcinoma
cells line, the p85/p110
N-terminal Domains of the Class IA Phosphoinositide
3-Kinase Regulatory Subunit Play a Role in Cytoskeletal but Not
Mitogenic Signaling*
§, and
Anatomy and Structural Biology, Albert Einstein College
of Medicine, Bronx, New York
PI 3-kinase is required for epidermal
growth factor (EGF)-stimulated lamellipod extension and
formation of new actin barbed ends at the leading edge of the cell. We
have now examined the role of the p85
regulatory subunit in greater
detail. Microinjection of recombinant p85
into MTLn3 cells blocked
both EGF-stimulated mitogenic signaling and lamellipod extension. In
contrast, a truncated p85(1-333), which lacks the SH2 and iSH2
domains and does not bind p110, had no effect on EGF-stimulated
mitogenesis but still blocked EGF-stimulated lamellipod extension.
Additional deletional analysis showed that the SH3 domain was not
required for inhibition of lamellipod extension, as a construct
containing only the proline-rich and breakpoint cluster region (BCR)
homology domains was sufficient for inhibition. Although the BCR domain
of p85 binds Rac, the effects of the p85 constructs were not because of
a general inhibition of Rac signaling, because sorbitol-induced JNK
activation in MTLn3 cells was not inhibited. These data show that the
proline-rich and BCR homology domains of p85 are involved in the
coupling of p85/p110 PI 3-kinases to regulation of the actin
cytoskeleton. These data provide evidence of a distinct cellular
function for the N-terminal domains of p85.
*
This work was funded in part by a grant from the American
Cancer Society and National Institutes of Health Grant RO1
GM556982 (to J. M. B) and by National Institutes of Health Training
Grant 5T32 GM07260 (to K. M. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
M. L. Janas, D. Hodson, Z. Stamataki, S. Hill, K. Welch, L. Gambardella, L. C. Trotman, P. P. Pandolfi, E. Vigorito, and M. Turner The Effect of Deleting p110{delta} on the Phenotype and Function of PTEN-Deficient B Cells J. Immunol., January 15, 2008; 180(2): 739 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Senft, B. Helfer, and S. M. Frisch Caspase-8 Interacts with the p85 Subunit of Phosphatidylinositol 3-Kinase to Regulate Cell Adhesion and Motility Cancer Res., December 15, 2007; 67(24): 11505 - 11509. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-y. Chuang, A. Valster, S. J. Coniglio, J. M. Backer, and M. Symons The atypical Rho family GTPase Wrch-1 regulates focal adhesion formation and cell migration J. Cell Sci., June 1, 2007; 120(11): 1927 - 1934. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Taniguchi, J. O. Aleman, K. Ueki, J. Luo, T. Asano, H. Kaneto, G. Stephanopoulos, L. C. Cantley, and C. R. Kahn The p85{alpha} Regulatory Subunit of Phosphoinositide 3-Kinase Potentiates c-Jun N-Terminal Kinase-Mediated Insulin Resistance Mol. Cell. Biol., April 15, 2007; 27(8): 2830 - 2840. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Vedham, H. Phee, and K. M. Coggeshall Vav Activation and Function as a Rac Guanine Nucleotide Exchange Factor in Macrophage Colony-Stimulating Factor-Induced Macrophage Chemotaxis Mol. Cell. Biol., May 15, 2005; 25(10): 4211 - 4220. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Leverrier, K. Okkenhaug, C. Sawyer, A. Bilancio, B. Vanhaesebroeck, and A. J. Ridley Class I Phosphoinositide 3-Kinase p110{beta} Is Required for Apoptotic Cell and Fc{gamma} Receptor-mediated Phagocytosis by Macrophages J. Biol. Chem., October 3, 2003; 278(40): 38437 - 38442. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Cousin, C. S. Malladi, T. C. Tan, C. R. Raymond, K. J. Smillie, and P. J. Robinson Synapsin I-associated Phosphatidylinositol 3-Kinase Mediates Synaptic Vesicle Delivery to the Readily Releasable Pool J. Biol. Chem., August 1, 2003; 278(31): 29065 - 29071. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Fu, E. Aronoff-Spencer, J. M. Backer, and G. J. Gerfen From the Cover: The structure of the inter-SH2 domain of class IA phosphoinositide 3-kinase determined by site-directed spin labeling EPR and homology modeling PNAS, March 18, 2003; 100(6): 3275 - 3280. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sturge, J. Hamelin, and G. E. Jones N-WASP activation by a {beta}1-integrin-dependent mechanism supports PI3K-independent chemotaxis stimulated by urokinase-type plasminogen activator J. Cell Sci., February 15, 2002; 115(4): 699 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Steinberg PI3King the L-Type Calcium Channel Activation Mechanism Circ. Res., October 12, 2001; 89(8): 641 - 644. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |